Inventor · disambiguated record
Robert Risinger
Also filed as: RISINGER ROBERT
8 granted patents·9 pending applications·7 citations·filing 2020–2024
81Inventor score
Files withBIOXCEL THERAPEUTICS INC17
Top patents by PatentIndex Score
17 records- 0195US11806334B1Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2023·Granted Nov 7, 2023·4 cites·5 claims
- 0293US11998529B2Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2023·Granted Jun 4, 2024·1 cites·18 claims
- 0393US11890272B2Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2022·Granted Feb 6, 2024·1 cites·25 claims
- 0492US12109196B2Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2024·Granted Oct 8, 2024·1 cites·25 claims
- 0588US12364683B2Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·18 claims
- 0688US12138247B2Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2024·Granted Nov 12, 2024·0 cites·6 claims
- 0786US12090140B2Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·6 claims
- 0885US2024173299A1Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0984US11998528B1Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2023·Granted Jun 4, 2024·0 cites·18 claims
- 1082US2024245650A1Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1171US2024024288A1Non-sedating dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1269US2025302808A1Dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1359US2025319069A1Methods for treating depressive statesBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1459US2022226288A1Dexmedetomidine treatment regimensBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2024024289A1Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochlorideBIOXCEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1648US2022395222A1Systems and methods for detection and prevention of emergence of agitationBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1747US2022202373A1Systems and methods of using machine learning to detect and predict emergence of agitation based on sympathetic nervous system activitiesBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Risinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →